Clinical trial / 2012
A low dose of lipidated curcumin altered several blood and saliva markers of wellness in healthy middle-aged adults.
A controlled study evaluated the effects of 80 mg/day of lipidated curcumin versus placebo for 4 weeks in healthy adults aged 40-60 years (N = 19 per group). Curcumin, but not placebo, led to statistically significant decreases in plasma triglycerides, salivary amylase, plasma beta amyloid protein, plasma sICAM, and plasma alanine amino transferase. It also led to statistically significant increases in salivary radical scavenging capacity, plasma catalase activities, plasma myeloperoxidase (without increased C-reactive protein), and plasma nitric oxide.
- Study type
- Controlled clinical trial
- Who was studied
- 38 healthy middle-aged people (40-60 years old; 19 curcumin, 19 placebo)
- What was measured
- Blood and saliva measures relevant to health promotion
THE PAPER
Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people.
DiSilvestro RA, Joseph E, Zhao S, Bomser J. Nutr J, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.